Collaborative Working with the NHS

Collaborating with the NHS to improve patient care

Teva works with NHS organisations at national, regional and local level, focussing on improving patient outcomes by implementing developments in healthcare delivery.

We’re focussed on helping patients get better access to the medicines they need, working on improving treatment options, and supporting the NHS’s drive to reduce costs. We are also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.

Collaborative Working with the NHS

We pride ourselves on taking our relationship with the NHS beyond the transactional into a more consultative and problem-solving partnership to help deliver better care in areas of mutual interest.

Active Collaborative Working Projects 

These Projects allow the pharmaceutical industry to work with healthcare organisations and other organisations with the aim to enhance patient care or is for the benefit of patients. Alternatively, collaborative working projects can be conducted to benefit the NHS and, as a minimum, maintain patient care.

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and Queen’s Medical Centre: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project is being undertaken to further improve the efficiency and delivery of the headache service at Queen’s Medical Centre

Project Period: Parties have committed resources to this project that will run for a period of 12 months, which can be extended if required and if agreed by all parties.  

The Project will aim to:

  • Facilitate the review of headache patients as per applicable guidelines
  • Improve the efficiency of the headache service and mitigate capacity and waiting list issues
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of headaches
  • Improve the use of NHS resources
  • Facilitate the development of a headache management pathway

Expected patient benefits for this Project include:

  • Improved patient experience of the service

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Effective use of NHS resources
  • Further establish headache management pathway and enhance existing services

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva 

For further information please contact us

Email Tel

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and University Hospital of North Midlands NHS Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project is being undertaken to improve the efficiency of the headache service at the Royal Stoke Hospital and improve patient experience and satisfaction.

Project Period: Parties have committed resources to this project that will run for a period of 6 months, which can be extended if required and if agreed by all parties.  

The Project will aim to:

  • Facilitate therapy eligibility, assessment and outcome response
  • Improve the efficiency of the headache service and mitigate capacity and waiting list issues
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of headaches
  • Improve the use of NHS resources
  • Collect patient survey data related to treatments and quality of the headache service

Expected patient benefits for this Project include:

  • Improved patient experience of the service

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Improved use of NHS resources
  • Establish headache management pathway and enhance existing services

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva

For further information please contact us

Email Tel

Completed Collaborative Working Projects

Outcome Summary of the Collaborative Working Agreement between Teva UK Limited and University Hospitals Sussex NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project aimed to facilitate the further improvement of the headache service, and the patient experience of the service, delivered at this Trust via the provision of short term nursing support.

Download the summary

Outcome Summary of the Collaborative Working Agreement between Teva UK Limited and Royal Free Hospital NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project aimed to facilitate the further improvement of the headache service, and the patient experience of the service, delivered at this Trust via the provision of short term nursing support.

Download the summary

Outcome Summary of the Collaborative Working Agreement between Teva UK Limited and Gloucestershire Hospital NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project aimed to facilitate the further improvement of the headache service, and the patient experience of the service, delivered at this Trust via the provision of short term nursing support.

Download the summary

Outcome Summary of the Collaborative Working Agreement between Teva UK Limited and St George’s University Hospitals NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project aimed to facilitate the further improvement of the headache service, and the patient experience of the service, delivered at this Trust via the provision of short term nursing support.

Download the summary

Joint Working

Joint Working projects are a specific type of partnership between the NHS and the pharmaceutical industry, which aim to improve the efficiency and delivery of patient care at a local level.

To ensure that the Joint Working projects we undertake are delivered to the highest standard, we follow the Department of Health’s Best Practice Guidance and the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.

We have undertaken a number of Joint Working initiatives with the NHS, in respiratory and migraine:

Active Joint Working Projects

Executive Summary of the Joint Working Agreement between Teva UK Limited and Guy’s and St Thomas’ NHS Foundation Trust: The HEADS-UP Project

Toggle Expand/ Collapse

The Project is being undertaken to improve diagnosis and clinical management, and therefore the outcomes and satisfaction experienced, in people suffering from a headache disorder. This will be achieved by: Optimising the patient journey from diagnosis to management; bringing care closer to home; ensuring that only appropriate referrals are made to the secondary/tertiary headache clinics. This will result in an enhancement of the level of patient care, and improved use of NHS resources.

Project Period: Both Parties have committed resources to this project that will run for a period of 12 months, which can be extended if required and if agreed by all parties.

The project is designed to:

  • Improve patient satisfaction with the healthcare service and deliver better care that is closer to home, by offering appropriate and timely headache management and access to headache specialists through a community clinic
  • Improve the efficiency of the King’s Health Partners (KHP) service and mitigate capacity, waiting lists, and failure to meet patient review targets
  • Enable quicker access to appropriate management, treatments, and care, by stratifying patients into different models of care that better reflect individual patient needs
  • Enhance the patient experience by providing a nurse-led clinic to educate patients on their disease, treatment choices, outcomes, and goals
  • Reduce headache-related hospital admissions
  • Implement and embed appropriate local, national, and NICE guidelines, for the treatment of headaches through the optimisation of treatment pathways
  • Improve education of healthcare professionals in: The disease area; treatments; new developments. This will be done through additional training and sharing best practices with other headache clinics
  • Improve the use of NHS resources
  • Audit and collect data on the impact of this project to allow outcome reporting and identification of any requirements for future service enhancement

Expected patient benefits for this project include:

  • More timely and appropriate diagnosis of the patient’s headache condition
  • Headache patients referred from primary care can be assessed in the community rather than in hospital, preventing travel into hospitals
  • Reduction in waiting time for patients with complex headache conditions
  • Accelerated access to appropriate treatments and care, by stratifying patients into different models of care that better reflect individual patient needs
  • Enhancing patient experience by providing a nurse-led clinic to educate patients on their: Disease, treatment choices, outcomes and goals
  • Increased quality of life through improved management
  • Reduced likelihood of unplanned hospital admissions

Expected NHS benefits for this project include:

  • Improved education of healthcare professionals in the disease area, as well as treatments and new developments. This will be done through additional training and sharing best practices with other headache clinics
  • Enhanced services that are configured around patient needs
  • Improved service efficiency
  • Reduction in the inappropriate use of secondary/tertiary NHS resources
  • Reduction in unplanned hospital admissions

Expected Teva benefits for this project include:

  • Increased awareness of Teva UK Limited within the headache therapy area
  • Demonstrating Joint Working capabilities for future projects and improving relationships with the NHS
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva
  • Project outcomes will demonstrate Teva’s effectiveness in working with the NHS to improve the management of headache and services delivered by KHP

For further information please contact us

Email Tel

Completed Joint Working Projects

Outcome Summary of the Joint Working Agreement between Teva UK Limited and The Walton Centre: Chronic Primacy Headache Service Review Project

Toggle Expand/ Collapse

The Project aimed to improve the clinical management, patient satisfaction and outcomes in adults patients diagnosed with chronic primary headache disorders in the Pan Mersey area.

Download the summary

For information on our completed Joint Working projects, please contact us:

Email Tel

 

Explore Teva in the UK

Teva is a big player on the world stage - that brings considerable benefits to patients in the UK

Learn more

Our contribution to UK healthcare

We’re proud to improve the health of millions of patients across the UK

Learn more
Date of preparation: May 2024
Reference: D: COB-GB-NP-00499 (V1.0) / T: COB-GB-NP-00500 (V1.0) / M: COB-GB-NP-00501 (V1.0)